Growth Metrics

Axogen (AXGN) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Axogen 2.00 Bn 1.90 Bn 46.19 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -494.95%
Dec 31, 2025 207.76%
Sep 30, 2025 46.01%
Jun 30, 2025 -618.82%
Mar 31, 2025 264.70%
Dec 31, 2024 83.74%
Sep 30, 2024 -305.52%
Jun 30, 2024 62.07%
Mar 31, 2024 -1,073.65%
Dec 31, 2023 -104.62%
Sep 30, 2023 -58.15%
Jun 30, 2023 1,922.14%
Mar 31, 2023 34.99%
Dec 31, 2022 -140.69%
Sep 30, 2022 30.36%
Jun 30, 2022 131.47%
Mar 31, 2022 46.70%
Dec 31, 2021 -100.46%
Sep 30, 2021 -63.03%
Jun 30, 2021 -577.82%
Mar 31, 2021 104.50%
Dec 31, 2020 8.41%
Sep 30, 2020 -241.16%
Jun 30, 2020 75.08%
Mar 31, 2020 -37.07%
Dec 31, 2019 1,375.14%
Sep 30, 2019 -81.56%
Jun 30, 2019 -35.73%
Mar 31, 2019 -9.06%
Dec 31, 2018 108.07%
Sep 30, 2018 -25,523.00%
Jun 30, 2018 17.56%
Mar 31, 2018 -1.70%
Dec 31, 2017 -76.45%
Sep 30, 2017 17.14%
Jun 30, 2017 -83.82%
Mar 31, 2017 52.58%
Dec 31, 2016 -78.77%
Sep 30, 2016 -228.05%
Jun 30, 2016 86.50%
Mar 31, 2016 -342.98%
Dec 31, 2015 57.39%
Sep 30, 2015 -74.54%
Jun 30, 2015 -286.62%
Mar 31, 2015 81.89%
Dec 31, 2014 -208.86%
Sep 30, 2014 37.66%
Jun 30, 2014 46.06%
Mar 31, 2014 -60.32%
Dec 31, 2013 -291.79%
Sep 30, 2013 -20.40%
Jun 30, 2013 53.06%
Mar 31, 2013 -659.45%
Dec 31, 2012 80.89%
Sep 30, 2012 -311.32%
Jun 30, 2012 86.37%
Mar 31, 2012 -95.13%
Dec 31, 2011 -100.50%
Sep 30, 2011 94,879.71%
Jun 30, 2011 57.91%
Mar 31, 2011 -21.91%
Dec 31, 2010 69.44%